RAB10 and Parkinson disease: Splitting the PD cases in the cohort between participants with high (e.g., pathogenic levels) ratios that exceed 50% from those with levels less than 50% highlights worse MDS-UPDRS part III scores in PD cases with higher Rab10 phosphorylation (Fig. 7D).